Jeffrey M. Besterman
Corporate Officer/Principal bij National Cancer Institute
Profiel
Jeffrey M.
Besterman is currently a Member-Special Review Committee at the National Cancer Institute.
Previously, he worked as the CSO and Executive VP-Research & Development at Mirati Therapeutics, Inc. from 2012 to 2013.
He also worked as the Head-Cell Biology Department at GlaxoSmithKline Research & Development.
Besterman holds a doctorate degree from the University of Vermont and an undergraduate degree from The State University of New York.
Actieve functies van Jeffrey M. Besterman
| Bedrijven | Functie | Begin |
|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Eerdere bekende functies van Jeffrey M. Besterman
| Bedrijven | Functie | Einde |
|---|---|---|
| MIRATI THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 14-03-2013 |
GlaxoSmithKline Research & Development
 GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Research & Development manufactures pharmaceutical products. It has locations in the U.S. and across Europe. The company has treatments in the works for therapies such as infectious diseases, neuroscientific requirements and respiratory needs. GlaxoSmithKline is located in Research Triangle Park, NC | Corporate Officer/Principal | - |
Opleiding van Jeffrey M. Besterman
| The State University of New York | Undergraduate Degree |
| University of Vermont | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
GlaxoSmithKline Research & Development
GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Research & Development manufactures pharmaceutical products. It has locations in the U.S. and across Europe. The company has treatments in the works for therapies such as infectious diseases, neuroscientific requirements and respiratory needs. GlaxoSmithKline is located in Research Triangle Park, NC | Health Technology |
